Ozonated triglyceride protects against septic lethality via preventing the activation of NLRP3 inflammasome.
10.11817/j.issn.1672-7347.2023.220634
- Author:
Dan WANG
1
;
Yuanhong LIU
2
;
Xiule ZONG
2
;
Siyu YAN
3
;
Jianyun LU
4
Author Information
1. Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013. Drdanwang@163.com.
2. Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013.
3. Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013. sunshine0719happy@163.com.
4. Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013. xiaoyun3@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
NLRP3 inflammasome;
ozonated oil;
ozonated triglyceride;
ozone therapy;
sepsis
- MeSH:
Animals;
Humans;
Mice;
Caspase 1;
Cytokines;
Disease Models, Animal;
Inflammasomes;
Lung Injury;
NLR Family, Pyrin Domain-Containing 3 Protein;
Ozone/therapeutic use*;
Sepsis/drug therapy*
- From:
Journal of Central South University(Medical Sciences)
2023;48(6):809-820
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Sepsis is a critical dysregulated host response with high mortality and current treatment is difficult to achieve optimal efficacy. Ozone therapy has been revealed to protect infection and inflammation-related diseases due to its role in antibiotic and immunoregulatory effect. Ozonated triglyceride is a key component of ozonated oil that is one of ozone therapy dosage form. However, the potential role of ozonated triglyceride in sepsis remains unclear. This study aims to explore the effect of ozonated triglyceride on septic mouse model and the molecular mechanism.
METHODS:Intraperitoneal injection of lipopolysaccharide (LPS), cecal ligation and puncture (CLP) were applied to construct septic mouse model. The mouse serum was obtained for detection of cytokines, and lung tissues were collected for hematoxylin and eosin (HE) staining to evaluate the extent of lung injury in septic mouse with ozonated triglyceride treatment at different time and doses. The survival of septic mice was observed for 96 h and Kaplan-Meier analysis was used to analyze the survival rates. In addition, primary peritoneal macrophages and human acute monocytic-leukemia cell line (THP-1) were treated with inflammasome activators with or without ozonated triglyceride. The level of cytokines was detected by enzyme-linked immunosorbent assay (ELISA). The cleavage of caspase-1 and gasdermin-D (GSDMD) was detected by Western blotting.
RESULTS:Ozonated triglyceride at different time and doses reduced the release of inflammasome-related cytokines [interleukin (IL)-1β and IL-18] (all P<0.05) but not pro-inflammatory cytokines such as IL-6 and tumor necrosis factor-α (TNF-α) in septic mice (all P>0.05). Ozonated triglyceride significantly improved the survival rate of septic mice and reduced sepsis-induced lung injury (all P<0.05). Ozonated triglyceride significantly suppressed the canonical and non-canonical activation of NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome (all P<0.05) but not affected absent in melanoma 2 (AIM2) and NLR family CARD domain-containing protein 4 (NLRC4) inflammasomes in vitro (all P>0.05). Ozonated triglyceride reduced the cleavage of caspase-1 and the downstream GSDMD.
CONCLUSIONS:Ozonated triglyceride presents a protect effect on sepsis lethality via reducing cytokines release and sepsis-related organ injury. The mechanism is that ozonated triglyceride specifically suppresses the activation of NLRP3 inflammasome. Ozonated triglyceride is a promising candidate for sepsis treatment.
